KROS

Healthcare

Keros Therapeutics, Inc.

$10.93-0.06 (-0.55%)

Prev Close

$10.99

Open

$11.02

High

$11.35

Low

$10.88

Volume

368.8K

Market Cap

$421.0M

P/E

7.01

Div Yield

—

Over the past 12 months, insider activity at Keros Therapeutics, Inc. (KROS) has been dominated by selling, with 1 insider purchase totaling $22.4K and 8 insider sales totaling $663.6K. The most recent insider transaction was by BIENAIME JEAN JACQUES (director), who purchased $22.4K worth of shares on Mar 11, 2026. Keros Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $421.0M.

Buys (12M)

$22.4K

Sells (12M)

$663.6K

Net Activity

Net Seller

$641.2K

Active Insiders

last 12 mo

KROS Price Chart

KROS Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Mar 11, 2026↗	BIENAIME JEAN JACQUES	director	Buy	2,000	$11.21	$22.4K	7,450
Feb 20, 2026↗	Cho Esther	officer: SVP, General Counsel	Sell	4,745	$16.35	$77.6K	39,755
Feb 20, 2026↗	Lerner Lorena Raquel	officer: Chief Science Officer	Sell	3,873	$16.35	$63.3K	31,127
Feb 20, 2026↗	Regnante Keith	officer: CHIEF FINANCIAL OFFICER	Sell	4,739	$16.35	$77.5K	39,261
Feb 20, 2026↗	Seehra Jasbir	director, officer: CHIEF EXECUTIVE OFFICER	Sell	7,015	$16.17	$113.4K	385,708
Feb 19, 2026↗	Seehra Jasbir	CHIEF EXECUTIVE OFFICER	Sell	7,015	$16.17	$113.4K	0
Feb 18, 2026↗	Cho Esther	SVP, General Counsel	Sell	4,745	$16.35	$77.6K	0
Feb 18, 2026↗	Lerner Lorena Raquel	Chief Science Officer	Sell	3,873	$16.35	$63.3K	0
Feb 18, 2026↗	Regnante Keith	CHIEF FINANCIAL OFFICER	Sell	4,739	$16.35	$77.5K	0

KROS Insider Buying Activity

The following table shows recent insider purchases of Keros Therapeutics, Inc. (KROS) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Mar 11, 2026↗	BIENAIME JEAN JACQUES	director	Buy	2,000	$11.21	$22.4K	7,450

KROS Insider Selling Activity

The following table shows recent insider sales of Keros Therapeutics, Inc. (KROS) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Feb 20, 2026↗	Cho Esther	officer: SVP, General Counsel	Sell	4,745	$16.35	$77.6K	39,755
Feb 20, 2026↗	Lerner Lorena Raquel	officer: Chief Science Officer	Sell	3,873	$16.35	$63.3K	31,127
Feb 20, 2026↗	Regnante Keith	officer: CHIEF FINANCIAL OFFICER	Sell	4,739	$16.35	$77.5K	39,261
Feb 20, 2026↗	Seehra Jasbir	director, officer: CHIEF EXECUTIVE OFFICER	Sell	7,015	$16.17	$113.4K	385,708
Feb 19, 2026↗	Seehra Jasbir	CHIEF EXECUTIVE OFFICER	Sell	7,015	$16.17	$113.4K	0
Feb 18, 2026↗	Cho Esther	SVP, General Counsel	Sell	4,745	$16.35	$77.6K	0
Feb 18, 2026↗	Lerner Lorena Raquel	Chief Science Officer	Sell	3,873	$16.35	$63.3K	0
Feb 18, 2026↗	Regnante Keith	CHIEF FINANCIAL OFFICER	Sell	4,739	$16.35	$77.5K	0